Artificial intelligence is a growing area in gastroenterology. It’s something NextServices President Praveen Suthrum predicted as an industry disruptor in his book, Scope Forward, and last year marked several advancements.
Here are seven updates since January 2020, starting with the most recent:
1. A partnership reached between Iterative Scopes and Eli Lilly Feb. 11 will explore how AI can improve understanding of inflammatory bowel disease pathophysiology and target identification. Iterative Scopes closed a $5.2 million seed round in January 2020.
2. Chattanooga, Tenn.-based Erlanger Health System started a clinical trial to test an AI device used to increase polyp detection during colonoscopies, according to a Feb. 9 report.